At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
Rubins Mastopexy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical, Randomized Study
In Brief
A clinical study evaluating Rubins Mastopexy and LOPOSAM for Weight Loss. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The purpose of this study is to compare two different techniques of mastopexy with autologous augmentation, the Lower Pole Subglandular Advancement Mastoplasty (LOPOSAM) and Rubins Mastopexy with autologous augmentation, in massive weight loss patients to see if one technique is superior to the other.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWeight Loss
CountriesDenmark
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartSep 2015
First PostedOct 2015
Primary CompletionNov 2017
TodayJul 2026
First PostedOct 8, 2015
Enrollment StartSep 1, 2015
Primary CompletionNov 16, 2017
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 10.7 years ago
Interventions
Rubins Mastopexyprocedure
The surgical technique described by Rubin is performed. No other intervention.
LOPOSAMprocedure
The surgical technique LOPOSAM is performed. No other intervention.